Preventive asthma medication discontinuation among children enrolled in fee-for-service Medicaid

  • Capo-Ramos D
  • Duran C
  • Simon A
 et al. 
  • 16

    Readers

    Mendeley users who have this article in their library.
  • 3

    Citations

    Citations of this article.

Abstract

Abstract Objective: Local-area studies demonstrate that preventive asthma medication discontinuation among Medicaid and Children's-Health-Insurance-Program (CHIP) enrolled children leads to adverse outcomes. We assessed time-to-discontinuation for preventive asthma medication and its risk factors among fee-for-service Medicaid/CHIP child beneficiaries. Methods: National-Health-Interview-Survey participants (1997-2005) with ≥1 Medicaid- or CHIP-paid claims when 2-17 years-old (n=4262) were linked to Medicaid-Analytic-eXtract claims (1999-2008). Multivariate Cox proportional-hazards models to assess time-to-discontinuation (i.e., failing to refill prescriptions

Author-supplied keywords

  • Asthma control
  • Children's health insurance program
  • Inhaled corticosteroids
  • Medication persistence
  • Patient adherence
  • Patient compliance
  • Preventive medicine

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • David E. Capo-Ramos

  • Catherine Duran

  • Alan E. Simon

  • Lara J. Akinbami

  • Kenneth C. Schoendorf

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free